Video

Dr. Rizk on the Evolution of Surgery in Lung Cancer

Nabil P. Rizk, MD, MS, MPH, discusses the evolving role of surgery in lung cancer.

Nabil P. Rizk, MD, MS, MPH, chief, Division of Thoracic Surgery, Hackensack University Medical Center, co-director, Thoracic Oncology, John Theurer Cancer Center, discusses the evolving role of surgery in lung cancer.

Historically, surgery and adjuvant chemotherapy were associated with significant morbidity in lung cancer, explains Rizk. ​Notably, only 50% of patients were able to tolerate adjuvant chemotherapy.

However, recovery for surgery has become much easier with the advent of minimally invasive and robotic approaches, Rizk adds. Now, patients can be released from the hospital within 1 ​to 3 days ​of undergoing a lobectomy, says Rizk. Then, patients are often eligible to start chemotherapy within 2 to 3 weeks.

As such, the argument that chemotherapy cannot be reliably administered in the adjuvant setting is no longer applicable with regard to minimally invasive surgery, Rizk concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity